4//SEC Filing
PUMA BIOTECHNOLOGY, INC. 4
Accession 0001209191-17-005352
$PBYICIK 0001401667operating
Filed
Jan 23, 7:00 PM ET
Accepted
Jan 24, 5:53 PM ET
Size
5.6 KB
Accession
0001209191-17-005352
Insider Transaction Report
Form 4
EYLER CHARLES R
SR. VP-FINANCE & TREASURER
Transactions
- Sale
COMMON STOCK
2017-01-20$33.24/sh−820$27,253→ 9,680 total
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 16, 2016 to satisfy tax obligations in connection with the vesting of restricted stock units.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.90 to $33.60, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Documents
Issuer
PUMA BIOTECHNOLOGY, INC.
CIK 0001401667
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001401667
Filing Metadata
- Form type
- 4
- Filed
- Jan 23, 7:00 PM ET
- Accepted
- Jan 24, 5:53 PM ET
- Size
- 5.6 KB